The following Business Section contains forward-looking statements. Our actual
results could differ materially from those anticipated in these forward-looking
statements as a result of certain risks, uncertainties and other factors
including the risk factors set forth in Part I, Item 1A of this annual report.
Unless the content requires otherwise, references to "ARIAD," "company," "we,"
"our," and "us," in this annual report refer to ARIAD Pharmaceuticals, Inc. and
ARIAD is a global oncology company focused on transforming the lives of cancer
patients with breakthrough medicines. Our mission is to discover, develop and
commercialize small-molecule drugs to treat cancer in patients with the greatest
unmet medical need - aggressive cancers where current therapies are inadequate.